If we want to address health inequalities, then cardiovascular disease prevention is a great place to start. For more information about our work in cardiovascular disease prevention, please contact Nick.Pringle@healthinnovationeast.co.uk, or firstname.lastname@example.org
Dr Max Hickman provides an overview of the Health Innovation East lipid management programme to support with improving the detection, prevention and treatment of CVD.
Dr Ahmet Fuat provides a comprehensive overview to support healthcare professionals to maximise opportunities around lipid management
Dr Max Hickman explains the importance of CVD and lipid management, including new pathways, guidance and novel therapies for healthcare professionals to improve the detection, prevention and treatment of CVD.
This seminar with Dr Paul Flynn, Cambridge University Hospitals NHS Foundation Trust, covered a review of recent guidelines, the criteria and pathway for genetic testing for suspected monogenic familial hypercholesterolaemia (FH), the eligibility criteria and pathway for starting PCSK9 inhibitors and the referral pathways for advice and review in the region’s lipid clinics.
Speaker: Dr Bharan Kumar, GP Lead, Bharani Medical Centre and Clinical Lead, Population Health, NHS Frimley ICS
An opportunity to hear from a wide range of speakers including: Dr Matt Kearney, Dr Max Hickman, Dr John Ford and an excellent patient story from Godwin Daudu covering topics related to optimising hypertension management in primary care.
Professor Ian Wilkinson provides an indepth overview of hypertension diagnosis and management.
This video is for any healthcare professionals across primary, secondary and tertiary care who look after patients with, or at high risk of developing, atherosclerotic cardiovascular disease to hear from an expert panel including: Dr Javier Gomez, Dr Kate Downes, Dr Paul Flynn and Shelina Rajan.
Hear Mark’s story and experience about being diagnosed and living with FH.
Dr Pegah Salashouri provides an overview of the latest guidelines in management of heart failure.
Dr Unni Krishnan a practical overview of the evidence and guidelines that support the use of combination antithrombotic therapy in patients who have a clinical indication for concurrent use of long term anticoagulant therapy as well as antiplatelet therapy for atherosclerotic vascular disease.
Professor Sir David Speigelhalter assess the trustworthiness of the way risks and uncertain evidence have been talked about during Covid. In particular, he will look at how background actuarial risk can be used to get a perspective on the risks facing those infected by the virus, and how the potential benefits and harms of vaccines can be communicated.
Do you have a great idea that could make a positive health impact?Get involved